The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer.
 
Patrick M. Forde
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Myriad Pharmaceuticals; Seagen
 
Kellie Smith
No Relationships to Disclose
 
Jamie E. Chaft
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca/MedImmune; Biodesix; Clovis Oncology; Genentech/Roche; Myriad Genetics
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Matthew David Hellmann
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Inovio Pharmaceuticals; Merck; Third Rock Ventures
Research Funding - Bristol-Myers Squibb
 
Taha Merghoub
No Relationships to Disclose
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Jounce Therapeutics; MedImmune; Merck; Polaris; Polynoma; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Stephen C. Yang
No Relationships to Disclose
 
Richard J. Battafarano
No Relationships to Disclose
 
Edward Gabrielson
Leadership - Taxus Cardium Pharmaceuticals
Stock and Other Ownership Interests - Taxus Cardium Pharmaceuticals
 
Christos Georgiades
No Relationships to Disclose
 
France Verde
No Relationships to Disclose
 
Gary L. Rosner
No Relationships to Disclose
 
Valsamo Anagnostou
No Relationships to Disclose
 
Victor E. Velculescu
Leadership - Personal Genome Diagnostics
Stock and Other Ownership Interests - Personal Genome Diagnostics
Honoraria - Janssen Diagnostics
Consulting or Advisory Role - Personal Genome Diagnostics
Patents, Royalties, Other Intellectual Property - Exact Sciences; Inostics; Myriad Genetics; Personal Genome Diagnostics; Qiagen
 
Suzanne Louise Topalian
Stock and Other Ownership Interests - Aduro Biotech (I); Compugen (I); Five Prime Therapeutics; Jounce Therapeutics (I); NexImmune (I); Potenza Therapeutics (I)
Consulting or Advisory Role - Amgen (I); Five Prime Therapeutics; GlaxoSmithKline; Inanovate; Jounce Therapeutics; MedImmune (I); Merck (I); Pfizer (I); Potenza Therapeutics (I); Sanofi (I)
Research Funding - Bristol-Myers Squibb; Compugen (I); Potenza Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Aduro Biotech (I); Bristol-Myers Squibb (I); Potenza Therapeutics (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Five Prime Therapeutics
 
Drew M. Pardoll
Consulting or Advisory Role - Pfizer
Research Funding - Bristol-Myers Squibb; Compugen; Potenza Therapeutics
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Pfizer
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck KGaA
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb